WO2009019047A1 - Eclaircissement enzymatique des fibres kératiniques - Google Patents

Eclaircissement enzymatique des fibres kératiniques Download PDF

Info

Publication number
WO2009019047A1
WO2009019047A1 PCT/EP2008/053075 EP2008053075W WO2009019047A1 WO 2009019047 A1 WO2009019047 A1 WO 2009019047A1 EP 2008053075 W EP2008053075 W EP 2008053075W WO 2009019047 A1 WO2009019047 A1 WO 2009019047A1
Authority
WO
WIPO (PCT)
Prior art keywords
hair
acid
oxidase
copolymer
agent
Prior art date
Application number
PCT/EP2008/053075
Other languages
German (de)
English (en)
Inventor
Thomas Schröder
Petra Somfleth
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Priority to EP08717817A priority Critical patent/EP2173317A1/fr
Publication of WO2009019047A1 publication Critical patent/WO2009019047A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair

Definitions

  • the invention relates to a mild lightening agent for keratinic fibers based on a special active ingredient combination consisting of a hair care composition and an enzymatic bleach system.
  • the invention further relates to the use of the enzymatic bleach system and the active ingredient combination for the preparation of mild brightening agents for keratinic fibers, a process for the preparation of mild brightening agents for keratinic fibers and a method for hair lightening using the agent.
  • the invention relates to a 2-component hair-lightening kit.
  • the product should also be able to alleviate unwanted or too dark hair coloring results by a uniform and natural brightening.
  • a hair-lightening agent which, in addition to a hair-care substance, contains a special enzymatic bleach system.
  • the invention therefore relates to natural, mild brightening agents for keratinic fibers, in particular for human hair, which contain a) at least one hair care substance and b) an enzymatic bleach system.
  • the brightening agents according to the invention lead to natural color shades, as they are usually caused by the action of the sun. In addition, they burden the hair much less than the usual in the art means, because they contain no hydrogen peroxide or aggressive acids. The additional content of hair care substances, the hair is cared for while lightening, and get more shine, smoothness and softness.
  • a significant advantage of the brightening agent according to the invention is that an hours-long UV exposure or chemical treatment of the hair is no longer necessary. As a result, not only instead of intensive, unnatural bleaching results even, natural color shades are achieved, but also made the treatment of hair less time consuming.
  • the hair treatment compositions according to the invention were also tested on hair which had given a hair dyeing process a too dark or undesirable color result, with the result that a natural and uniform lightening in both cases led to a much more satisfactory result for the consumer.
  • the bleach system according to the invention is composed of i) an oxidase, ii) a substrate for the oxidase and iii) a peroxidase.
  • an oxidase suitable according to the invention is understood as meaning glucose oxidase, a substrate suitable for the oxidase D-glucose according to the invention and a peroxidase lactoperoxidase which is suitable according to the invention.
  • the hair lightening agents contain substantially no further bleach components, in particular no hydrogen peroxide.
  • the substrate ii) - based on its total weight - further contains a maximum of 1 wt .-% iodide and Thiocyanationen.
  • the bleach system according to the invention is in the brightening agent - based on the total agent - usually in an amount of 0.01 to 10 wt .-%, preferably from 0.1 to 5 wt .-% and in particular from 0.5 to 2.0 Wt .-%, wherein the components i), ii) and iii) of the bleach system in a weight ratio of (0.1 - 1): (10 - 50): (0.1 - 1), preferably in a weight ratio of 0.5: 20: 0.5.
  • the brightening agents according to the invention for carrying out the objects according to the invention contain at least one hair care substance, which is a hair structure-improving and / or a hair-conditioning active ingredient.
  • Examples of such hair structure-improving and / or hair-conditioning active ingredients are vitamins and their derivatives or precursors.
  • panthenol and its physiologically tolerated derivatives are in particular the esters and ethers of panthenol as well as cationically derivatized panthenols.
  • Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829 A1.
  • An inventively preferred panthenol derivative is also its precursor pantolactone. Panthenol is preferred within this group.
  • Another example of a structurally improving vitamin is pyridoxine (vitamin B6).
  • PVP polyvinylpyrrolidone
  • aldehydes particularly effective, structurally improving compounds are the aldehydes.
  • Particularly preferred examples are formaldehyde and formaldehyde-releasing compounds, such as methoxymethyl esters, dimethylol (thio) urea derivatives, oxazolidine derivatives, N-hydroxymethylmaleimide, hexamethylenetetramine and its derivatives, hydantoin derivatives, pyridinium-substituted Dimethyl ether, imidazolidinyl urea derivatives, isothiazolinones, 2-bromo-2-nitropropane-diol and 5-bromo-5-nitro-1,3-dioxane.
  • Further particularly preferred aldehydes are acetaldehyde, glyoxal, glyceraldehyde and glutaric dialdehyde.
  • Another suitable group of structurally-improving active ingredients are plant extracts.
  • compositions according to the invention are the extracts of almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi, melon and green tea.
  • alcohols and mixtures thereof can be used.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred.
  • Extra kte plants based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture.
  • compositions according to the invention mixtures of several, especially two, different plant extracts.
  • honey extracts are obtained in an analogous manner to the plant extracts and usually contain 1-10 wt .-%, in particular 3-5 wt .-%, of active substance. Water / propylene glycol mixtures may also be preferred extractants here.
  • Further structurally improving active substances are protein hydrolysates, in particular elastin, collagen, keratin, milk protein, soy protein, almond protein and wheat protein hydrolysates, their condensation products with fatty acids and quaternized protein hydrolysates. Particularly preferred are greatly degraded keratin hydrolysates having molecular weights in the range of 400 to 800.
  • quaternized protein hydrolysates such as those under the trade names Gluadin ® WQ (INCI name: Lauridimonium Hydroxypropyl Hydrolyzed Wheat Protein) and Crotein ® Q (INCI name: Hydroxypropyltrimonium Hydrolyzed collagen) are sold, particularly preferred according to the invention.
  • quaternary polymers are inventively preferred structure-improving compounds are particularly preferred polymers are those available under the trade names Mirapol ® A15 (INCI name: Polyquaternium-2)., Onamer ® M (INCI name: Polyquaternium-1), Merquat ® 100 (INCI name: Polyquaternium-6), Merquat ® 550 (INCI name: Polyquaternium-7) and polymer JR 400 (INCI name: Polyquaternium-10) are distributed.
  • fiber structure-improving agents are mono-, di- and oligosaccharides such as glucose, galactose, fructose, fructose, sucrose and lactose. Furthermore, derivatives of these pentoses, hexoses and heptoses, such as the corresponding on- and uronic acids (sugar acids), sugar alcohols, sugar amines, such as N-glucosamine, and glycosides, and with C 4 -C 30 fatty alcohols etherified pentoses, hexoses and heptoses to be used according to the invention.
  • sugar acids can be used according to the invention in free form, in the form of their salts, preferably calcium, magnesium and zinc salts, and in the form of their esters or lactones.
  • Preferred sugar acids are gluconic acid, gluconic acid-Y-lactone, lactobionic acid, glucuronic acid and its mono- or dilactones, pangamic acid, sugar acid, mannose and its mono- or dilactones, as well as mucic acid and its mono- or dilactones.
  • Preferred sugar alcohols are sorbitol, mannitol and dulcitol.
  • Preferred glycosides are the methylglucosides. Glucose, N-glucosamine and gluconic acid are particularly preferred from this group.
  • Certain amino acids can also be used in the context of the present invention as hair structure-improving active ingredients.
  • Examples are the amino acids serine, threonine and tyrosine described in DE-195 22 569, to which reference is expressly made.
  • derivatives of serine, such as the serine phosphate are also preferred according to the invention.
  • Another structurally-improving amino acid is lysine.
  • Serine is a particularly preferred fiber-structure-improving agent.
  • acids in particular ⁇ -hydroxycarboxylic acids, and their salts can be used.
  • Structure-improving acids which are preferred according to the invention are lactic acid, malic acid, tartaric acid, glyceric acid and Maleic acid. Lactic acid and glyceric acid are particularly preferred.
  • special phosphonic acids and their salts improve the structure of keratin-containing fibers.
  • Phosphonic acids preferred according to the invention are the n-octylphosphonic acid and the n-decylphosphonic acid.
  • lipid-soluble ester alcohols or ester polyols are known for their structure-improving action. They are considered to be lipid-soluble if 5% by weight of these products in cetyl alcohol dissolve clearly at 80 ° C.
  • the ester alcohols or ester polyols which are suitable according to the invention are obtainable by reacting an epoxy fatty acid ester with water or mono- or polyhydric alcohols having 1-10 carbon atoms with opening of the epoxide ring and forming a vicinal dihydroxyethyl or hydroxyalkoxyethyl group.
  • the epoxy fatty acid ester may also be an epoxidation product of a technical fatty acid ester with proportions of saturated fatty acids.
  • the epoxy oxygen content should be at least 3% by weight, preferably 5-10% by weight.
  • the epoxy fatty acid esters are either epoxidized fatty acid esters of monohydric alcohols, e.g. epoxidized oleic acid methyl ester, linoleic acid methyl ester, ricinoleic acid methyl ester or epoxidized fatty acid esters of polyhydric alcohols, e.g. Glycerol monooleate or propylene glycol monooleate or epoxidized fatty acid triglycerides, e.g. Oleic acid triglyceride or unsaturated oils, e.g. Olive oil, soybean oil, sunflower oil, linseed oil, rapeseed oil.
  • monohydric alcohols e.g. epoxidized oleic acid methyl ester, linoleic acid methyl ester, ricinoleic acid methyl ester
  • epoxidized fatty acid esters of polyhydric alcohols e.g. Glycerol monoo
  • unsaturated fatty acid methyl ester epoxides from unsaturated vegetable fatty acids.
  • the reaction product of a vegetable oil fatty acid methyl ester epoxide with a polyol having 2 to 6 C atoms and 2 to 6 hydroxyl groups is particularly preferred as ester polyol.
  • polyols e.g. Ethylene glycol, 1, 2-propylene glycol, 1, 3-propylene glycol, butanediol, pentanediol, hexanediol, glycerol, trimethylolpropane, pentaerythritol, sorbitol or diglycerol.
  • the novel bleach ester polyol is the reaction product of a DefettTexremethylester epoxidate with trimethylolpropane and having a hydroxyl number from 350 - 450.
  • a product based on epoxy and SojaölfettTexremethylester- trimethylolpropane is available under the trade name Sovermol ® 760th
  • vitamin B 3 can be used as structure-improving active ingredient.
  • the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • the nicotinic acid amide is preferred.
  • Vitamin H can also be used as structurally improving active ingredient in the context of the present invention.
  • Vitamin H the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] - imidazole-4-valeric acid, for which but in the meantime the common name biotin has prevailed.
  • Structure-improving active ingredients which are particularly preferred according to the invention are selected from panthenol, physiologically tolerated panthenol derivatives, mono-, di- and oligosaccharides, serine, lactic acid, glyceric acid, niacinamide, vitamin B6, polyvinylpyrrolidone, glucose, gluconic acid, biotin and the lipid-soluble ester alcohols or ester polyols.
  • the agents according to the invention contain the structure-improving and / or hair-conditioning active ingredient (s), preferably in amounts of from 0.01 to 10% by weight, preferably from 0.05 to 5% by weight and in particular of from 0.1 to 2 wt .-%.
  • the brightening agents in a further, particularly preferred embodiment of the invention, it is advantageous for the brightening agents to contain at least one thickener for stabilization.
  • Polymers regardless of their chemical structure and charge, generally have multiple functions in cosmetic compositions.
  • the description of the polymers according to their function in the compositions according to the invention thus does not necessarily correspond to an evaluation or significance of these polymers. Rather, all polymers are in principle to be considered equivalent for use in the compositions of the invention, although some of these polymers may be preferred.
  • Polymers can increase the viscosity of aqueous and non-aqueous phases in cosmetic preparations.
  • aqueous phases their viscosity-increasing function is due to their solubility in water or their hydrophilic nature. They are used in both surfactant and emulsion systems.
  • Acrylamide Copolymer Acrylamide / Sodium Acrylate Copolymer, Acrylamide / Sodium Acryloyl Dimethyl Taurate Copolymer, Acrylates / Acetoacetoxyethyl Methacrylate Copolymer, Acrylates / Beheneth-25 Methacrylate Copolymer, Acrylates / C 10-30 Alkyl Acrylate Crosspolymer, Acrylates / Ceteth-20 Itaconate Copolymer, Acrylates / Ceteth-20 Methacrylate Copolymer, Acrylates / Laureth-25 Methacrylate Copolymer, Acrylates / Palmeth-25 Acrylate Copolymer, Acrylates / Palmeth-25 Itaconate Copolymer, Acrylates / Steareth-50 Acrylate Copolymer, Acrylates / Steareth-20 Itaconate Copolymer, Acrylates / Steareth-20 Methacrylate Copolymer, Acrylates / Stearyl
  • Another way to increase the viscosity of cosmetic products is the thickening of the non-aqueous phase, the lipid phase of the cosmetic products.
  • polymers are used which are not water-soluble but compatible with lipids. They are also used for the gelation of cosmetic products with high lipid levels.
  • the emulsion-stabilizing polymers are also among the polymers preferred according to the invention. These are understood to mean polymers which essentially support the structure and the stabilization of emulsions (O / W and W / O as well as multiple emulsions). Surfactants and emulsifiers are of course the essential ingredients, but the stabilizing polymers contribute to a reduction in the coalescence of the emulsified droplets by positively affecting the continuous or disperse phase. This positive influence may be due to an electrical repulsion, an increase in viscosity or a film formation on the surface of the droplets. These properties of the polymers in question can also be used to particular advantage in the compositions according to the invention in order to keep the active substances, the modified titanium dioxide particles, according to the invention, stably dispersed in the compositions according to the invention.
  • Examples of such polymers are Acrylamide / Sodium Acryloyl Dimethyl Taurate Copolymer, Acrylates / Amino Acrylates / C 10-30 Alkyl PEG-20 Itaconate Copolymer, Acrylates / C 10-30 Alkyl Acrylate Crosspolymer, Acrylates / Stearyl Methacrylate Copolymer, Acrylates / Vinyl Isodecanoate Crosspolymer, Alcaligenes Polysaccharides , AIIyI Methacrylates Crosspolymer, Ammonium Acryloyldimethyltaurate / Beheneth-25 Methacrylate Crosspolymer, Ammonium Acryloyldimethyltaurate / Vinyl Formamide Copolymer, Ammonium Alginate, Ammonium Phosphatidyl Rapeseedate, Ammonium Polyacrylate, Ammonium Polyacryloyldimethyl Taurate, Ammonium Shellacate, Arachidyl Alcohol, Astragalus Gummi
  • Particularly preferred thickening and / or suspending polymers are acrylamide copolymer, acrylamide / sodium acrylate copolymer, acrylamide / sodium acryloyldimethyltaurate copolymer, acrylates / beheneth-25 methacrylate copolymer, acrylates / C 10-30 alkyl acrylate crosspolymer, acrylates / ceteth-20 itaconate copolymer , chitosan, carbomer, guar hydroxypropyltrimonium chloride, hectorite, Hydrated silica, Hydrogenated Potato Starch, hydroxypropyl starch, hydroxypropyl Starch phosphates, hydroxypropyl xanthan gum, and the products sold under the trade names Carbopol ®, Pemulen ®, Jaguar ®, Acrysol ® or Salcare ®.
  • the polymers which have a thickening and / or suspending action are preferably contained in the compositions according to the invention in amounts of from 0.01 to 30% by weight, based on the total composition. Amounts of from 0.01 to 25, in particular from 0.01 to 15 wt .-%, are particularly preferred. Most preferred are amounts of from 0.05% by weight to 5.0% by weight, based in each case on the entire composition.
  • the brightening agents according to the invention are not subject to any restrictions with regard to their formulation form and can be formulated as emulsion, cream, solution, gel or mousse.
  • compositions according to the invention are shampoos, hair rinses, and
  • Hair conditioners conditioners, hair lotions, hair gels, hair sprays, hair foams, hair fixatives,
  • Hair lotions and hair colorants in particular hair rinses, hair treatments,
  • compositions according to the invention may furthermore contain all active substances, additives and auxiliaries known for such preparations.
  • the brightening agents contain at least one surfactant, wherein in principle both anionic and zwitterionic, ampholytic, nonionic and cationic surfactants are suitable.
  • the agent of the invention is formulated as a rinse-off product such as a hair shampoo, it has been found to be advantageous to select the surfactants from anionic, zwitterionic or nonionic surfactants.
  • the agent according to the invention is formulated as a leave-on product, for example a hair conditioner, a hair conditioner or a hair conditioner, it has proved to be advantageous that it contains at least one cationic surfactant.
  • the agent according to the invention is formulated as a shampoo, it also contains at least one anionic, amphoteric, zwitterionic and / or nonionic surfactant.
  • the total surfactant content in the cleaning agents is 5 to 35%, preferably 7 to 25% and in particular 8 to 15% - based on the total weight of the cleaning agent.
  • Suitable anionic surfactants in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. Example, a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • anionic surfactants are, in each case in the form of the sodium, potassium and ammonium and the mono-, di- and trialkanol- ammonium salts having 2 to 4 carbon atoms in the alkanol group, linear and branched fatty acids having 8 to 30 C. Atoms (soaps),
  • Ethercarbon Acid the formula RO- (CH2-CH2 ⁇ ) ⁇ -CH2-COOH, in which R is a linear
  • Alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 16, acylsarcosides having 8 to 24 carbon atoms in the acyl group, acyl taurides having 8 to 24 carbon atoms in the acyl group, acyl isethionates having 8 to 24 carbon atoms in the acyl group,
  • Sulfobernsteinklamono- and -dialkylester having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester with 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefinsulfonates with 8 to 24 carbon atoms, alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms,
  • alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12, mixtures of surface-active hydroxysulfonates, sulfated Hydroxyalkylpolyethylen- and / or Hydroxyalkylenpropylenglykolether according to DE-A-37 23 354,
  • Esters of tartaric acid and citric acid with alcohols which are addition products of about 2-15 molecules of ethylene oxide and / or propylene oxide onto fatty alcohols having 8 to 22 C atoms, alkyl and / or alkenyl ether phosphates of the formula (II),
  • OX in the R 6 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R 7 is hydrogen, a radical (CH 2 CH 2 O) n R 6 or X, n is from 1 to 10 and X is hydrogen, an alkali metal radical or alkaline earth metal or NR 8 R 9 R 10 R 11 , where R 8 to R 11 independently of one another represent a C 1 to C 4 hydrocarbon radical, is a sulfated fatty acid alkylene glycol ester of the formula (III),
  • CH 2 O (CH 2 CH 2 O) 2 -SO 3 X in the R, 13 C .. O is a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for 0 or for numbers of 1 to 30, preferably 2 to 10, and X is an alkali or alkaline earth metal.
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid in the form of their sodium salts.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acid salts having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group, sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups and the alkali metal and / or ammonium salts of Tridecethsulfats.
  • Particularly preferred anionic surfactants are the alkali metal or ammonium salts of lauryl ether sulfate having a degree of ethoxylation of 2 to 4 EO and the alkali metal and / or ammonium salts of trideceth sulfate.
  • Zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO () or -SO 3 ⁇ group.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinates, for example cocoacylaminopropyl-dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Amphoteric surfactants are to be understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts
  • suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C
  • Nonionic surfactants contain as hydrophilic group z.
  • Such compounds are, for example
  • Polyol fatty acid esters such as the commercially available product ® Hydagen HSP (Cognis) or Sovermol - types (Cognis), alkoxylated triglycerides, alkoxylated fatty acid alkyl ester of formula (V) (V) in the R 14 CO is a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, R 15 is hydrogen or methyl, R 16 is linear or branched alkyl radicals having 1 to 4 carbon atoms and w is a number from 1 to 20 stands,
  • Alkyl polyglycosides can only contain one particular alkyl radical R. Usually, however, these compounds are starting from natural fats and oils or
  • sugar building block Z it is possible to use any desired mono- or oligosaccharides.
  • sugars with 5 or 6 carbon atoms and the corresponding oligosaccharides are used.
  • Such sugars are, for example, glucose, fructose, galactose, arabinose, ribose, xylose, lyxose, allose, altrose, mannose, gulose, idose, talose and sucrose.
  • Preferred sugar building blocks are glucose, fructose, galactose, arabinose and sucrose; Glucose is particularly preferred.
  • alkyl polyglycosides which can be used according to the invention contain on average from 1.1 to 5 sugar units. Alkyl polyglycosides having x values of 1.1 to 2.0 are preferred. Very particular preference is given to alkyl glycosides in which x is 1: 1 to 1, 8.
  • the alkoxylated homologs of said alkyl polyglycosides can also be used according to the invention. These homologs may contain on average up to 10 ethylene oxide and / or propylene oxide units per alkyl glycoside unit.
  • the preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is usually preferred to start from the production of these substances from native plant or animal raw materials, so as to obtain substance mixtures with different, depending on the particular raw material alkyl chain lengths.
  • both products with a "normal” homolog distribution and those with a narrow homolog distribution can be used.
  • "normal” homolog distribution are meant mixtures of homologs obtained in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Narrowed homolog distributions are obtained when, for example, hydrotalcites, alkaline earth metal salts of ether carboxylic acids, alkaline earth metal oxides, hydroxides or alkoxides are used as catalysts. The use of products with narrow homolog distribution may be preferred.
  • surfactant mixtures of crosslinked or uncrosslinked anionic surfactants such as sodium trideceth sulfate, amphoteric surfactants such as sodium lauroamphoacetate, and nonionic surfactants such as cocamide MEA, such as those commercially available under the tradename Miracare SLB 365 MP, have been found to be particularly suitable Surfactant base exposed.
  • the agents according to the invention furthermore comprise at least one preservative selected from the group which is formed Benzoic acid, propionic acid, salicylic acid and / or sorbic acid, and from the cosmetically acceptable salts and esters of these acids, from formaldehyde and / or paraformaldehyde, from benzyl alcohol, Germall, Dowicil, Kathon, Baypival, methylisothiazolines, quaternary ammonium compounds, alcohols and / or from ethereal Oils such as tea tree oil, cineole, eugenol, geraniol, limonene, menthol and / or thymol.
  • composition according to the invention is formulated as a shampoo
  • this agent may be preferred for this agent to comprise at least one antidandruff agent in an amount of from 0.05 to 5% by weight, preferably from 0.1 to 3.0% by weight. % and in particular from 0.3 to 2.0 wt .-% (based on the total agent).
  • compositions according to the invention are not formulated as shampoos (and thus predominantly as cleansing agents), but as hair treatment compositions with predominantly nourishing properties, they furthermore preferably contain cationic surfactants.
  • a shampoo according to the invention may also have a content of cationic surfactants.
  • Cationic surfactants suitable according to the invention are quaternary ammonium compounds or so-called ester quats.
  • Preferred quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • alkyltrimethylammonium chlorides dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride as well as the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An inventively particularly suitable compound from this group of substances under the name Tegoamid ® S 18 commercial stearamidopropyl dimethylamine is.
  • the cationic surfactants are contained in the agents according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Hair rinses, hair treatments, hair lotions, hair gels, hair sprays, hair foams, hair fixatives, hair lotions and hair colorants according to the invention can contain further components customary in these compositions.
  • the inventive composition further contains at least one member of the group of cationic, nonionic, anionic and / or aphoteren polymers, water-insoluble wax and oil components, UV filters, amino acids, water-insoluble silicones, water-soluble silicones and / or amodimethicone.
  • a shampoo according to the invention which, in addition to a good cleaning effect, also has nourishing properties, it may be advantageous to contain one or more of the abovementioned components.
  • Cationic polymers which are suitable according to the invention are polymers which have groups in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • “permanently cationic” refers to those polymers which have a cationic group independently of the pH of the agent These are generally polymers which contain a quaternary nitrogen atom, for example in the form of an ammonium group Preferred cationic groups are quaternary ammonium groups .
  • R 17 -H or -CH 3
  • R 18, R 19 and R 20 are independently selected from C- ⁇ - 4 -alkyl, -alkenyl or -hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is a natural number
  • X ' is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (III) and nonionic monomer units are particularly preferred cationic polymers.
  • R 17 is a methyl group
  • R 18 , R 19 and R 20 are methyl groups m has the value 2.
  • Suitable physiologically tolerated counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.
  • a suitable homopolymer is, if desired, crosslinked, poly (methacryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium- 37.
  • the crosslinking can, if desired, using poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglycerylether, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI Designation: PPG-1-trideceth-6)) are commercially available.
  • Copolymers containing monomer units according to formula (VI) as the non-ionic monomer preferably acrylamide, methacrylamide, acrylic acid-C - ⁇ - alkyl ester and methacrylic acid-C- ⁇ - 4 -alkyl.
  • the acrylamide is particularly preferred.
  • These copolymers can also be crosslinked, as described above in the case of the homopolymers.
  • a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • Such copolymers in which the monomers are present in a weight ratio of about 20:80 are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
  • Other preferred cationic polymers are, for example, quaternized cellulose derivatives, such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, hydrophobically modified cellulose derivatives, for example those sold under the trade name SOFTCAT ® cationic polymers, cationic alkyl polyglycosides, cationized honey, for example the commercial product Honeyquat ® 50 , cationic guar derivatives, in particular those sold under the trade names cos media ® guar and Jaguar ® products,
  • Polysiloxanes with quaternary groups such as the commercially available products Q2-7224 (manufacturer: Dow Corning; a stabilized trimethyl silylamodimethicon), Dow Corning ® 929 Emulsion (containing a hydroxylamino-modified silicone which is also known as amodimethicone ), SM-2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th.
  • Copolymers of vinylpyrrolidone with quaternized derivatives of Dialkylaminoalkylacry- lats and methacrylate such as diethyl sulfate quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers.
  • Such compounds are available under the names Gafquat ® 734 and Gafquat ® 755 commercially, vinylpyrrolidone-vinyl imidazolium copolymers, such as those offered under the names Luviquat ® FC 370, FC 550, FC 905 and HM 552, quaternized polyvinyl alcohol, as well as the under the names Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and
  • Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.
  • Can be used as cationic polymers are sold under the names Polyquaternium-24 (commercial product z. B. Quatrisoft ® LM 200), known polymers. Also usable according to the invention are the copolymers of vinylpyrrolidone, as they are known as Commercial products Copolymer 845 (manufacturer: ISP), Gaffix ® VC 713 (manufacturer: ISP), Gafquat ® ASCP 1011, Gafquat ® HS 110 Luviquat.RTM ® 8155 and Luviquat.RTM ® MS are available 370th
  • cationic polymers of the present invention are usually contain an amino group present at certain pH values as a quaternary ammonium group and hence cationic.
  • chitosan and its derivatives are preferred, such as for example, under the trade designations Hydagen ® CMF, Hydagen® ® HCMF, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially.
  • chitosans are deacetylated, in different degrees of deacetylation and varying degrees of degradation (molecular weights) are commercially available. Their preparation is, for example, in DE 44 40 625 A1 and described in DE 1 95 03 465 A1.
  • Particularly useful chitosans have a degree of deacetylation of at least 80% and a molecular weight of 5 '10 5 to 5' 10 6 (g / mol).
  • the chitosan must be converted into the salt form. This can be done by dissolving in dilute aqueous acids.
  • acids both mineral acids, e.g. Hydrochloric acid, sulfuric acid and phosphoric acid as well as organic acids, e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids suitable.
  • organic acids e.g. low molecular weight carboxylic acids, polycarboxylic acids and hydroxycarboxylic acids suitable.
  • higher molecular weight alkyl sulfonic acids or alkyl sulfuric acids or organophosphoric acids can be used, provided that they have the required physiological compatibility.
  • Suitable acids for converting the chitosan into the salt form are e.g.
  • Acetic acid, glycolic acid, tartaric acid, malic acid, citric acid, lactic acid, 2-pyrrolidinone-5-carboxylic acid, benzoic acid or salicylic acid Preferred are low molecular weight hydroxycarboxylic acids such as e.g. Glycolic acid or lactic acid.
  • the cationic polymer used is at least one polymer from the group of cationic guar derivatives and / or polyquaternium-7 (Merquat 550), polyquaternium-6, polyquaternium-10, polyquaternium-37, polyquaternium-67 (SoftCat ® polymers) and / or a chitosan in the hair treatment compositions.
  • the cationic polymer (s) is (are) in the inventive compositions - based on the total agent - in amounts of 0.1 to 5 wt .-%. Amounts of from 0.2 to 3, in particular from 0.5 to 2.5 wt .-%, are particularly preferred.
  • Suitable water-insoluble oil components according to the invention are mineral or synthetic oils, as well as mixtures of these components.
  • mineral oils are used in particular mineral oils, paraffin and Isoparaffinöle and synthetic hydrocarbons.
  • An inventively employable hydrocarbon is for example that available as a commercial product 1, 3-di- (2-ethylhexyl) - cyclohexane (Cetiol ® S).
  • Suitable synthetic oils are silicone compounds, in particular dialkyl and alkylaryl silicones, such as, for example, dimethylpolysiloxane and methylphenylpolysiloxane, as well as their hydroxy-terminated, alkoxylated and quaternized analogs.
  • silicones are those sold by Dow Corning under the names DC 190, DC 200, DC 344 and DC 345 (cyclomethicone).
  • oil component may further serve a dialkyl ether.
  • Dialkyl ethers which can be used according to the invention are, in particular, di-n-alkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as, for example, di-n-octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n-alkyl ether.
  • n-undecyl ether di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether and Di-tert-butyl ether, di-iso-pentyl ether, di-3-ethyl decyl ether, tert-butyl n-octyl ether, iso-pentyl-n-octyl ether and 2-methylpentyl-n-octyl ether.
  • di-n-octyl ether which is commercially available under the name Cetiol ® OE.
  • the agents according to the invention preferably contain the water-insoluble oil component in an amount range from 0.1 to 5% by weight, in particular from 0.5 to 3% by weight, based on the total weight of the composition.
  • the effect of the active compound combination according to the invention can be further optimized by further fatty substances.
  • Other fatty substances are to be understood fatty acids and natural and synthetic waxes, which may be present both in solid form and liquid in aqueous dispersion.
  • the fatty acids used can be linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms. Among these could be mentioned, for example, isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linoleic and erucic acid and their technical mixtures, for example in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from the Roelen oxosynthesis or the dimerization of unsaturated fatty acids.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean. In a preferred embodiment, the amount is 0.5-10% by weight, very particularly preferably amounts of 1-5% by weight.
  • the natural or synthetic waxes used according to the invention are solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • fatty substances are, for example
  • Dicarboxylic acid esters such as di-n-butyl adipate, di- (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecyl acelate
  • diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2- ethylhexanoate), propylene glycol diisostearate, propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylglykoldicaprylat, symmetrical, asymmetric or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl carbonate (Cetiol ® CC).
  • the amount of other fatty substances used is 0.1 to 20% by weight, based on the total agent. Preference is given to 0.1-10% by weight and more preferably 0.1-5% by weight, based on the total agent.
  • the total amount of oil and fat components in the compositions according to the invention is usually from 0.01 to 15% by weight, based on the total agent. Amounts of 0.05-5 wt .-% are inventively preferred.
  • the effect of the preparations can be increased by UV filters.
  • the UV filters to be used according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum is in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range are suitable. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the UV filters used according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.
  • UV filters which can be used according to the invention are 4-aminobenzoic acid, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate (homosalates), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ® M 40, Uvasorb MET ®, ® Neo Heliopan BB, Eusolex ® 4360), 2-phenylbenzimidazole-5-sulfonic acid and potassium, sodium and triethanolamine salts ( Phenylbenzimidazole Sulfonic Acid; Parsol ® HS; Neo Heliopan Hydro ®), 3,3 '- (1, 4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo-bicyclo [2.2.1] hept-1- yl-methane sulfonic acid) and salts thereof, 1- (4-tert-butyl
  • 2-hydroxy-4-methoxybenzophenone 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts
  • 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) -propane 1, 3-dione, 4-methoxycinnamic acid 2-ethylhexyl ester and 3- (4'-methylbenzylidene) -D, L-camphor.
  • water-insoluble UV filters are those which dissolve in water at not more than 1% by weight, in particular not more than 0.1% by weight, at 20 ° C. Furthermore, these compounds should be soluble in the usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-%). The use of water-insoluble UV filters may therefore be preferred according to the invention.
  • UV filters which have a cationic group, in particular a quaternary ammonium group.
  • UV filters have the general structure U - Q.
  • the structural part U stands for a UV-absorbing group.
  • This group can in principle be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is replaced by a cationic group Q, in particular having a quaternary amino function ,
  • Compounds from which the structural part U can be derived are, for example, substituted benzophenones, p-aminobenzoic acid esters,
  • Structural parts U which are derived from cinnamic acid amide or from N, N-dimethylaminobenzoic acid amide are preferred according to the invention.
  • the structural parts U can in principle be chosen so that the absorption maximum of the UV filters both in the UVA (315-400 nm) -, as well as in the UVB (280-315nm) - or in the UVC ( ⁇ 280 nm) - Area can lie.
  • the structural part U also as a function of structural part Q, is preferably selected so that the molar extinction coefficient of the UV filter at the absorption maximum is above 15,000, in particular above 20,000.
  • the structural part Q preferably contains, as a cationic group, a quaternary ammonium group.
  • This quaternary ammonium group can in principle be connected directly to the structural part U, so that the structural part U represents one of the four substituents of the positively charged nitrogen atom.
  • one of the four substituents on the positively charged nitrogen atom is a group, especially an alkylene group of 2 to 6 carbon atoms, which functions as a compound between the structural portion U and the positively charged nitrogen atom.
  • the group Q has the general structure - (CH 2 ) X -N + R 1 R 2 R 3 X ' , in which x is an integer from 1 to 4, R 1 and R 2 independently of one another are d 1
  • x preferably represents the number 3
  • R 1 and R 2 each represent a methyl group and R 3 represents an alkyl group or a benzyl group and
  • X represents a physiologically tolerable anion 3 either for a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms.
  • Physiologically acceptable anions are, for example, inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.
  • inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.
  • UV filters with cationic groups are the commercially available compounds cinnamic acid-trimethylammonium chloride (lncroquat ® UV-283) and dodecyl tosylate (Escalol ® HP 610).
  • the teaching of the invention also includes the use of a combination of several UV filters.
  • the combination of at least one water-insoluble UV filter with at least one UV filter with a cationic group is preferred.
  • the UV filters (I) are contained in the compositions according to the invention usually in amounts of 0.1-5 wt .-%, based on the total agent. Levels of 0.4-2.5 wt .-% are preferred.
  • the compositions also contain at least one volatile or non-volatile, water-insoluble silicone, water-soluble and / or amino-functionalized silicone.
  • suitable silicones cause a variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine.
  • silicones the skilled person understands several structures of organosilicon compounds.
  • Dimethiconols (S1) form the first group of silicones which are particularly preferred according to the invention.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (S1-I):
  • Branched dimethiconols can be represented by the structural formula (S1-II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of dimethicones are zwiscAhen 1000D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 CPs, especially preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the dimethiconols may already be present as an emulsion.
  • the corresponding emulsion of the dimethiconols can be prepared both after the preparation of the corresponding dimethiconols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of the dimethiconols can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.
  • the droplet size of the emulsified particles according to the invention is 0.01 ⁇ m to 10,000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m, and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering. If branched dimethiconols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly. For the purposes of the present invention, branched dimethiconols are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethiconols can be very particularly preferred.
  • Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF
  • these compositions contain from 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and especially 0 , 5 to 5 wt.% Dimethiconol based on the composition.
  • dimethicones S2
  • S2 Linear dimethicones
  • Branched dimethicones can be represented by the structural formula (S2 - II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • linear polydialkylsiloxanes particularly preference is given in accordance with the invention to the linear polydialkylsiloxanes, the polyalkylaryl siloxanes, the polydiarylsiloxanes and / or the dihydroxypolydimethylsiloxanes.
  • the molecular weights of the dimethicones suitable according to the invention are between 1000 D and 10,000,000 D.
  • suitable dimethicones are usually between 0.01 and 10,000,000 cPs measured at 25 0 C using a glass capillary viscometer according to the Dow Corning Corporate Test Method CTM 0004 of 20 July 1970.
  • Preferred viscosities are between 0.1 and 5,000,000 cPs, completely particularly preferred viscosities are between 0.1 and 3,000,000 cps.
  • the most preferred viscosity range of dimethicones is between 0.6 and 600,000 cps.
  • the teaching of the invention also includes that the dimethicones may already be present as an emulsion.
  • the corresponding emulsion of the dimethicones can be prepared both after the preparation of the corresponding dimethicones from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicones can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.
  • the droplet size of the emulsified particles according to the invention is 0.01 ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethicones are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethicones are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is the Amount of tri- and tetrafunctional siloxanes, determined. According to the invention, both low-branched and highly branched dimethicones can be very particularly preferred.
  • these compositions contain from 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and especially 0 , 5 to 5% by weight of dimethicone, based on the composition.
  • Dimethicone copolyols (S3) form another group of preferred silicones.
  • Dimethiconols can be represented by the following structural formulas:
  • Branched dimethicone copolyols can be represented by the structural formula (S3-III):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halogenated hydrocarbon radicals, such as 3-chloropropyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CHz) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • PE stands for a polyoxyalkylene radical.
  • Preferred polyoxyalkylene radicals are derived from ethylene oxide, propylene oxide and glycerol.
  • the numbers x, y and z are integers and each run independently from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cps, particularly preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the Dimethiconcopolymere can already be present as an emulsion.
  • the corresponding emulsion of the dimethicone copolyols can be prepared both after the preparation of the corresponding dimethicone copolyols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicone copolyols can also be prepared directly by an emulsion polymerization process.
  • the droplet size of the emulsified particles according to the invention is 0.01 ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethicone copolyols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethicone copolyols are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching Monomers, that is, the amount of tri- and tetrafunctional siloxanes determined.
  • both low-branched and highly branched dimethicone copolyols can be very particularly preferred.
  • these compositions contain from 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and especially 0 , 5 to 5 wt.% Dimethiconecopolyol based on the composition.
  • Aminofunctional silicones or also called amodimethicones (S4), are silicones which have at least one (optionally substituted) amino group.
  • Such silicones may e.g. by the formula (S4-I)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms
  • Q is a polar radical of the general formula -R 1 HZ, wherein R 1 is a divalent connecting group attached to hydrogen and the Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms;
  • "a” assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 1 to about 3
  • "a” + “b” is less than or equal to 3
  • "c” is a number in the range from about 1 to about 3
  • x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25
  • y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000
  • M is a suitable silicone end
  • Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, A-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, - C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for Z is NH (CH 2 ) Z NH 2 , wherein z is 1 or more.
  • Another possible formula for Z is -NH (CH 2 ) Z (CH 2 ) ZZ NH, wherein both z and zz are independently 1 or more, which structure includes diamino ring structures, such as piperazinyl.
  • Z is most preferably a -NHCH 2 CH 2 NH 2 radical.
  • Z is - N (CH 2 ) Z (CH 2 ) ZZ NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and z is 0.
  • Q is most preferably a polar, amine functional group of the formula CH 2 CH 2 CH 2 NHCH 2 CH 2 NH 2 .
  • "a” assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 2 to about 3
  • "a” + “b” is less than or equal to 3
  • the molar ratio of R a Q b SiO (4 a . b) / 2 units to the R 0 SiO (4. C) / 2 units is in the range from about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20.
  • Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-II)
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -
  • R ' is a monovalent radical selected from o -N (R ") - CH 2 -CH 2 - N (FT) 2 o -N (FT) 2 o -N + (R") 3 A- -N + H o (R ") 2 A " o -N + H 2 (R ") A " o -N (R ”) - CH 2 -CH 2 -N + R” H 2 A " where each R" is the same or different Radicals from the group -H, -phenyl, -benzyl, the C 1 -C 20 -alkyl radicals, preferably -CH 3 , -CH 2 CH 3 , - C ⁇ 2 C ⁇ 2 C ⁇ 3 , - (_ / H ((- / H 3 ) 2 , -C ⁇ 2 C ⁇ 2 C ⁇ 2 H 3 , - (- / H 2 C'H ((- / H 3 ) 2 , - (- / H ((_
  • A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.
  • agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-IM)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
  • compositions according to the invention which are characterized in that they contain an amino-functional silicone of the formula (S4-IV) are also particularly preferred.
  • n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are referred to as amodimethicones according to the INCI declaration.
  • agents according to the invention are preferred in which the amino-functional silicone has an amine number above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g ,
  • the amine number stands for the milliequivalents of amine per gram of amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • these compositions contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5 wt.% And in particular 0.5 to 5 wt.% Of amodimethicone based on the composition.
  • the mixing ratio is largely variable.
  • all silicones used for mixing are used in a ratio of 5: 1 to 1: 5 in the case of a binary mixture.
  • a ratio of 3: 1 to 1: 3 is particularly preferred.
  • Very particularly preferred mixtures contain all the silicones contained in the mixture largely in a ratio of about 1: 1, in each case based on the amounts used in wt.%.
  • these compositions contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight, and especially 0.5 to 5% by weight of silicone mixture based on the composition.
  • the effect of the active ingredient combination according to the invention can be increased by emulsifiers.
  • emulsifiers are, for example
  • Alkylphenols having 8 to 15 C atoms in the alkyl group having 8 to 15 C atoms in the alkyl group
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which bind to C-atom 3 of the
  • Steroid scaffolds carry a hydroxyl group and both from animal tissue
  • Zoosterins are cholesterol and lanosterol. Examples of suitable phytosterols are
  • Ergosterol, stigmasterol and sitosterol are also used to isolate sterols, the so-called mycosterols.
  • Phospholipids include, in particular, the glucose phospholipids which are obtained, for example, as lecithins or phosphatidylcholines from, for example, egg yolks or plant seeds (for example soybeans).
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol, polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • Linear and branched fatty acids with 8 to 30 carbon atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • polymers can further support the action of the preparations according to the invention.
  • polymers are therefore added to the compositions according to the invention, both anionic, amphoteric and nonionic polymers having proven effective.
  • anionic polymers which can support the action of the preparations according to the invention are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as sole or co-monomer have proven to be particularly effective
  • Sulfonic acid group may be wholly or partially present as sodium, potassium, ammonium, mono- or triethanolammonium salt.
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid which is available for example under the name Rheothik ® 11-80 is commercially.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer.
  • anionic monomers reference is made to the substances listed above.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a special preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • This copolymer may also be crosslinked, with crosslinking agents preferably polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide are used.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • the use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (C 13 -C 14 isoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous within the scope of the teaching according to the invention.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate 80 Natriumacryloyldimethyltaurat copolymers have proven to be particularly effective according to the invention.
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether, especially those with crosslinks, are also color-retaining polymers.
  • a 1, 9-decadiene crosslinked maleic acid-methyl vinyl ether copolymer is available under the name Stabileze® QM ® commercially available.
  • amphoteric polymers can be used as polymers to increase the activity of the preparations according to the invention.
  • amphoteric polymers includes both those polymers which contain both free amino groups and free COOH or SO 3 H groups in the molecule and are capable of forming internal salts, as well as zwitterionic polymers which contain quaternary ammonium groups and COO in the molecule ' or -SO 3 ' groups, and those polymers comprising -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphopolymer suitable is the acrylic resin commercially available as Amphomer ®, which is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1, 3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Represents methacrylic acid and its simple esters.
  • Amphomer ® is a copolymer of tert-butylaminoethyl methacrylate, N- (1, 1, 3,3-tetramethylbutyl) -acrylamide and two or more monomers from the group of acrylic acid, Represents methacrylic acid and its simple esters.
  • amphoteric polymers are those polymers which are composed essentially
  • R 4 and R 5 independently of one another are alkyl groups having 1 to 4 carbon atoms, Z is an NH 4
  • n is an integer from 2 to 5 and A is the anion of an organic or inorganic acid
  • R 6 -CH CR 7 -COOH (G 3 -II) in which R 6 and R 7 are independently hydrogen or methyl groups.
  • the agents according to the invention may contain nonionogenic polymers.
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy-, as sold for example under the trademark Culminal® ® and Benecel ® (AQUALON). shellac
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • Glycosidically substituted silicones according to EP 0612759 B1. It is also possible according to the invention that the preparations comprise a plurality of, in particular two, different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
  • the polymers are preferably contained in the inventive compositions in amounts of from 0.05 to 10% by weight, based on the total agent. Amounts of 0.1 to 5, in particular from 0.1 to 3 wt .-%, are particularly preferred.
  • a second aspect of the invention is a kit containing a first and a second phase which, when combined, yield a composition containing at least one hair care agent, an oxidase, a substrate for the oxidase and a peroxidase, the first and the second phase are physically separate from each other and the first phase contains at least one hair care agent, an oxidase and a peroxidase, and the second phase contains a substrate for the peroxidase.
  • kits which a) in the first phase at least one hair care composition selected from panthenol, physiologically acceptable panthenol derivatives, mono-, di- and oligosaccharides, serine, glyceric acid, niacinamide, vitamin B6, polyvinylpyrrolidone, gluconic acid, biotin , lipid-soluble ester alcohols or ester polyols, nonionic and / or cationic polymers, volatile and / or nonvolatile, water-soluble and / or water-insoluble silicones, animal or vegetable protein hydrolysates and / or their derivatives, glucose oxidase and lactoperoxidase and b) in the second phase D-glucose and at most 1 wt .-% (based on the D-glucose) iodide and thiocyanate ions.
  • a hair care composition selected from panthenol, physiologically acceptable panthenol derivatives, mono-, di- and
  • a third aspect of the invention is the use of an enzymatic bleach system consisting of a mixture of an oxidase, a substrate for the oxidase and a peroxidase, as a mild lightening agent for keratinic fibers, in particular for human hair.
  • an enzymatic bleaching system for brightening human hair which contains oxidase as glucose oxidase, as substrate D-glucose and as peroxidase lactoperoxidase.
  • a fourth object of the invention is the use of a combination of the enzymatic bleach system according to the invention and at least one hair care substance for the gentle lightening of keratinic fibers, in particular human hair.
  • the brightening agents according to the invention which, in addition to the enzymatic bleach system, contain no further bleaching agents, in particular no hydrogen peroxide.
  • a fifth object of the invention is a process for the preparation of a natural, mild whitening agent for keratinic fibers based on an enzymatic bleach system which i. an oxidase, ii. a substrate for the oxidase and iii. a peroxidase, wherein the component ii) and the components i) and iii) are not incorporated as a mixture, but separately in the agent.
  • the brightening agent further contains at least one hair structure improving and / or hair conditioning agent selected from panthenol, physiologically acceptable panthenol derivatives, mono-, di- and oligosaccharides, serine, glyceric acid, niacinamide, vitamin B6, polyvinylpyrrolidone, gluconic acid, biotin, lipid-soluble ester alcohols or ester polyols, nonionic and / or cationic polymers, volatile and / or nonvolatile, water-soluble and / or water-insoluble silicones, animal or vegetable protein hydrolysates and / or derivatives thereof.
  • at least one hair structure improving and / or hair conditioning agent selected from panthenol, physiologically acceptable panthenol derivatives, mono-, di- and oligosaccharides, serine, glyceric acid, niacinamide, vitamin B6, polyvinylpyrrolidone, gluconic acid, biotin, lipid-soluble
  • a sixth object of the invention is a method for the gentle lightening of keratinic fibers, in particular human hair, in which a brightening agent according to the invention is applied to the hair, and optionally after an exposure time of 30 seconds up to 2 hours, preferably not at all, rinsed out again.
  • ®8 INCI name Distearoylethyl Hydroxyethylmonium Methosulfate, Cetearyl Alcohol;
  • Active ingredient cationic surfactant: 65 - 72%; Cognis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des agents éclaircissants légers naturels pour les fibres kératiniques, en particulier pour les cheveux humains, qui contiennent: a) au moins une substance de soin des cheveux et b) un système de décoloration enzymatique. La décoloration des cheveux à l'aide de cet agent éclaicissant permet d'obtenir des nuances de couleur naturelles et d'éclaircir naturellement les cheveux de couleur foncée.
PCT/EP2008/053075 2007-08-08 2008-03-14 Eclaircissement enzymatique des fibres kératiniques WO2009019047A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08717817A EP2173317A1 (fr) 2007-08-08 2008-03-14 Eclaircissement enzymatique des fibres kératiniques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200710037432 DE102007037432A1 (de) 2007-08-08 2007-08-08 Enzymatische Aufhellung keratinischer Fasern
DE102007037432.3 2007-08-08

Publications (1)

Publication Number Publication Date
WO2009019047A1 true WO2009019047A1 (fr) 2009-02-12

Family

ID=39469759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/053075 WO2009019047A1 (fr) 2007-08-08 2008-03-14 Eclaircissement enzymatique des fibres kératiniques

Country Status (3)

Country Link
EP (1) EP2173317A1 (fr)
DE (1) DE102007037432A1 (fr)
WO (1) WO2009019047A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3148651A4 (fr) * 2014-06-02 2017-10-18 Avon Products, Inc. Composition d'éclaircissement topique et ses procédés d'utilisation
CN110087623A (zh) * 2016-12-20 2019-08-02 高露洁-棕榄公司 两相口腔护理增白组合物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120065115A1 (en) * 2010-09-12 2012-03-15 Landra Booker Johnson CARA B Naturally - Shampoo / Body Wash
EP3641725A1 (fr) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition et procédé permettant d'améliorer l'aspect de la peau
CA3102288A1 (fr) 2018-07-03 2020-01-09 The Procter & Gamble Company Methode de traitement d'une affection cutanee
EP4157206A1 (fr) 2020-06-01 2023-04-05 The Procter & Gamble Company Méthode d'amélioration de la pénétration d'un composé de vitamine b3 dans la peau
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723354A1 (de) 1987-07-15 1989-01-26 Henkel Kgaa Sulfatierte hydroxy-mischether, verfahren zu ihrer herstellung und ihre verwendung
US4961925A (en) * 1987-03-31 1990-10-09 Kyowa Hakko Kogyo Co., Ltd. Hair preparation composition
DE3926344A1 (de) 1989-08-09 1991-02-28 Henkel Kgaa Verfahren zur herstellung von hellfarbigen oelsaeuresulfonaten
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
WO1991011105A1 (fr) * 1990-02-03 1991-08-08 The Boots Company Plc Compositions anti-microbiennes
WO1992013829A1 (fr) 1991-02-06 1992-08-20 Smith Ronald J Composes quaternaires de panthenol et utilisation desdits composes
DE4440625A1 (de) 1994-11-14 1996-05-15 Henkel Kgaa Verfahren zur Herstellung hellfarbiger Chitosane
DE19503465A1 (de) 1995-02-03 1996-08-08 Henkel Kgaa Verfahren zur Herstellung von niedrigviskosen kationischen Biopolymeren
EP0612759B1 (fr) 1993-02-26 1996-10-02 Wacker-Chemie GmbH Composés organosilicié comportant un reste glycosidique et procédé pour leur préparation
DE19736906A1 (de) 1997-08-25 1999-03-04 Henkel Kgaa Verfahren zur Herstellung von sulfatierten Fettsäurealkylenglykolestern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
EP1157684A2 (fr) * 2000-05-15 2001-11-28 L'oreal Composition oxydante et utilisations pour la teinture, pour la déformation permanente ou pour la décoloration des fibres kératiniques
DE102005062646A1 (de) * 2005-12-23 2007-06-28 Henkel Kgaa Bleichmittel, enthaltend Urease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483308A (en) 1968-10-24 1969-12-09 Texas Instruments Inc Modular packages for semiconductor devices

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961925A (en) * 1987-03-31 1990-10-09 Kyowa Hakko Kogyo Co., Ltd. Hair preparation composition
DE3723354A1 (de) 1987-07-15 1989-01-26 Henkel Kgaa Sulfatierte hydroxy-mischether, verfahren zu ihrer herstellung und ihre verwendung
DE3926344A1 (de) 1989-08-09 1991-02-28 Henkel Kgaa Verfahren zur herstellung von hellfarbigen oelsaeuresulfonaten
DE3929973A1 (de) 1989-09-08 1991-03-14 Henkel Kgaa Haarpflegemittel
WO1991011105A1 (fr) * 1990-02-03 1991-08-08 The Boots Company Plc Compositions anti-microbiennes
WO1992013829A1 (fr) 1991-02-06 1992-08-20 Smith Ronald J Composes quaternaires de panthenol et utilisation desdits composes
EP0612759B1 (fr) 1993-02-26 1996-10-02 Wacker-Chemie GmbH Composés organosilicié comportant un reste glycosidique et procédé pour leur préparation
DE4440625A1 (de) 1994-11-14 1996-05-15 Henkel Kgaa Verfahren zur Herstellung hellfarbiger Chitosane
DE19503465A1 (de) 1995-02-03 1996-08-08 Henkel Kgaa Verfahren zur Herstellung von niedrigviskosen kationischen Biopolymeren
DE19736906A1 (de) 1997-08-25 1999-03-04 Henkel Kgaa Verfahren zur Herstellung von sulfatierten Fettsäurealkylenglykolestern
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
EP1157684A2 (fr) * 2000-05-15 2001-11-28 L'oreal Composition oxydante et utilisations pour la teinture, pour la déformation permanente ou pour la décoloration des fibres kératiniques
DE102005062646A1 (de) * 2005-12-23 2007-06-28 Henkel Kgaa Bleichmittel, enthaltend Urease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ARCH PERSNAL CARE PRODUCTS: "Biomimetic bodywash BP-6", XP002485793, Retrieved from the Internet <URL:http://www.archchemicals.com/Fed/PC/Docs/BP-6_Biomimetic_Bodywash.pdf> [retrieved on 20080625] *
ARCH PERSONAL CARE PRODUCTS: "Product Data Biovert Enzyme and Substrate", 6 November 2007 (2007-11-06), XP002485794, Retrieved from the Internet <URL:http://www.archchemicals.com/Fed/PC/Docs/Biovert_v2.1.pdf> [retrieved on 20080625] *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3148651A4 (fr) * 2014-06-02 2017-10-18 Avon Products, Inc. Composition d'éclaircissement topique et ses procédés d'utilisation
CN110087623A (zh) * 2016-12-20 2019-08-02 高露洁-棕榄公司 两相口腔护理增白组合物
CN110087623B (zh) * 2016-12-20 2022-05-10 高露洁-棕榄公司 两相口腔护理增白组合物

Also Published As

Publication number Publication date
EP2173317A1 (fr) 2010-04-14
DE102007037432A1 (de) 2009-02-12

Similar Documents

Publication Publication Date Title
EP2037877B1 (fr) Shampoing antipelliculaire
EP2056785A2 (fr) Produit capillaire à effet structurant composé de silicones hydrosolubles et de polymères cationiques sélectionnés
WO2008017540A1 (fr) Agent de lutte contre les produits de desquamation de la tête
EP1970045A2 (fr) Produit de traitement capillaire ayant un effet anti-pelliculaire
EP1800715A1 (fr) Système cosmétique (kit) de traitement des cheveux et du cuir chevelu
DE102008050430A1 (de) Anti-Schuppen- und Anti-Rückfall-Shampoo
WO2009019047A1 (fr) Eclaircissement enzymatique des fibres kératiniques
WO2008080701A1 (fr) Compositions cosmétiques contenant des acides gras choisis et du squalène
EP1977728A2 (fr) Stabilisation de produits comprenant des tensioactifs
EP1789010B1 (fr) Melange de principes actifs pour traiter des fibres keratiniques
DE102008036073A1 (de) Reinigungsmittel mit Terpolymer
DE102004040172A1 (de) Kompakthaarspray
EP1691772A1 (fr) Agent cosmetique volumisant
WO2008074576A1 (fr) Composition conditionnante de polymères amphotères ou cationiques et de tensioactifs anioniques doux spécialement sélectionnés dans des moyens de traitement de fibres kératiniques
WO2006018328A2 (fr) Laque capillaire concentree
DE10358780A1 (de) Versprühbares Gel
WO2008080702A2 (fr) Poudre minérale naturelle dans des produits cosmétiques
WO2008080682A2 (fr) Combinaison synergique de protéines de soie et de métaux sélectionnés
WO2009019046A1 (fr) Agent de traitement des cheveux pour augmenter le volume de ces derniers
EP1900772A2 (fr) Fixation de forme de matériaux contenant des fibres à l&#39;aide de polymères
WO2007042085A1 (fr) Stabilisation de silicones insolubles dans l&#39;eau
DE102009031432A1 (de) Kompaktes Haarspray
WO2008025679A1 (fr) Composition de principes actifs cosmétique contenant de l&#39;extrait de bois de santal
WO2006066641A1 (fr) Produit pour traiter des cheveux blonds presentant une coloration verdatre
WO2006021259A1 (fr) Methode de soin pour fibres keratiniques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08717817

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008717817

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE